Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Duvelisib in Combination With Nivolumab for Patients With Richter's Syndrome and Transformed Follicular Lymphoma

NCT03892044 is registered in ClinicalTrials.gov with David Bond, MD as lead sponsor.

NCT NCT03892044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03892044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Duvelisib in Combination With Nivolumab for Patients With Richter's Syndrome and Transformed Follicular Lymphoma
Lead sponsor
David Bond, MD
Phase
Phase 1
Overall status
Completed
Start date
November 5, 2019
Completion date
February 14, 2024
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, recurrent diffuse large b-cell lymphoma, refractory diffuse large b-cell lymphoma, richter syndrome, small lymphocytic lymphoma, transformed chronic lymphocytic leukemia to diffuse large b-cell lymphoma, transformed follicular lymphoma to diffuse large b-cell lymphoma, transformed small lymphocytic lymphoma to diffuse large b-cell lymphoma